A recent study from Peter Greer’s lab (Cancer Biology & Genetics, QCRI) has been published in Cancer Research Communications.
This collaborative work shows that targeting the adaptor protein Ezrin can improve chemotherapy response and reduce metastasis in preclinical breast cancer models.
This paper builds on longterm collaborations (Bruce Elliott, Sonal Verma and Chris Nicol), and was supported by Canadian Cancer Society, CIHR & MITACs). Read all about it here:
https://aacrjournals.org/cancerrescommun/article/doi/10.1158/2767-9764.CRC-21-0117/699206/Targeting-the-ezrin-adaptor-protein-sensitizes?sf165209328=1